The Neuroplatform: Towards a Comprehensive Mechanistic QSP Model of Alzheimer’s Disease for Supporting Drug Discovery and Development
With over 55 million people diagnosed worldwide, Alzheimer’s disease presents a significant public health challenge, with treatment costs and caregiver burden reaching staggering figures, expected to exceed a trillion dollars soon. Explore the latest insights into Alzheimer’s disease and drug development in Dr. Hugo Geerts’ presentation at the University of Indiana. Learn about the development … Continued